Most Recent
A judge has rejected Amaca's bid for indemnity costs in a case over contributions to an asbestos class action settlement, but he did not rule on the company's novel argument that a settlement resulting from mediation could count as the outcome of litigation in awarding costs.
IP Australia handed a win Thursday to a company challenging a Bayer animal drug patent, but gave Bayer an additional two months to address its concerns about the patent application's deficiencies.
The Commonwealth Bank of Australia on Friday pushed back against the majority of expanded claims brought by the anti-money laundering regulator and denied all allegations in the related class action.
A group of Linfox workers in Victoria has lost their bid to put a Fair Work appeal on ice while they challenge a commissioner's ruling that found in favor of the logistics giant in a dispute over their jobs.
The ACCC has set out its priorities for 2018, and bigger penalties for big business flouting competition laws is top of the agenda, the commission's chief said Tuesday.
Drug giants GlaxoSmithKline and Novartis have conceded part of the ACCC's case that packaging on their Voltaren Osteo Gel breached the Australian Consumer Law, but said the label was changed almost a year ago.
The judge who sided with Medibank in the ACCC's failed case last year paid little attention to one of the consumer regulator's central arguments against the private health insurer, a court heard Monday.
Airport workers protested Friday as the Federal Court prepared to hear arguments in a case over whether staff can be made to work split shifts.
The Australian Patent Office wants the Federal Court to uphold its decision refusing an application by marketing technology start-up Rokt for a patent covering its online advertising system, offering fresh justification.
In the first criminal prosecution of its kind against an Australian corporation, prosecutors on Thursday charged a Victorian health care company and its managing director over an alleged wheelchair cartel.